Cipla Q2FY23 Results: Net profit up 12% Rs 797 crore

Its total revenue from operations rose to Rs 5,829 crore for the September quarter from Rs 5,520 crore in the year-ago period, Cipla said in a regulatory filing.

Cipla Q2FY23 Results: Net profit up 12% Rs 797 crore
The Mumbai-based drug maker had reported a consolidated net profit of Rs 709 crore in the July-September period of the previous fiscal. (Photo credit: Reuters)

Drug major Cipla on Friday said its consolidated net profit increased 12 per cent to Rs 797 crore for the second quarter ended September 30.

The Mumbai-based drug maker had reported a consolidated net profit of Rs 709 crore in the July-September period of the previous fiscal.

Its total revenue from operations rose to Rs 5,829 crore for the September quarter from Rs 5,520 crore in the year-ago period, Cipla said in a regulatory filing.

In respect of the transfer of India-based US business undertaking, the board decided not to proceed with the proposed transfer, considering various factors, including the current operating environment, it added.

Also Read: RBI MPC Meeting Outcome - Discussion, drafting of report for government on inflation | Latest News, Result, Updates

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/photo-gallery-top-7-small-cap-sip-mutual-funds-with-highest-return-gains-in-10-years-calculator-inr-rs-11111-monthly-investment-in-no-1-scheme-has-sprung-to-5730613-nifty-bse-sbi-hdfc-quant-nippon-axis-aum-nav-index-337442

Top 7 Small Cap Mutual Funds With Best SIP Returns in 10 Years: Rs 11,111 monthly SIP investment in No 1 fund has sprung to Rs 57,30,613; know about others too

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-mutual-fund-sip-retirement-corpus-calculator-how-much-amount-can-rs-15000-monthly-investment-generate-in-20-30-40-years-market-linked-return-337565

Power of Compounding: How large corpus can Rs 15,000 monthly SIP generate in 20, 30, and 40 years?

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-latest-fd-rates-for-senior-citizens-and-others-know-what-publuc-lender-is-giving-on-rs-10-lakh-deposits-in-1-year-3-years-5-years-tenure-fixed-deposit-return-calculator-online-337233

SBI Latest FD Rates: This is what you can get on Rs 10 lakh investment in 1-year, 3-year, and 5-year tenures

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-fd-444-day-amrit-vrishti-vs-bank-of-baroda-bob-400-fixed-deposit-maturity-return-interest-rate-calculator-amount-on-inr-rs-600000-and-1000000-investments-for-senior-and-general-citizens-337493

SBI 444-day FD vs Bank of Baroda 400-day FD: What will be maturity amounts on Rs 6 lakh and Rs 10 lakh investments for general and senior citizens?

https://www.zeebiz.com/personal-finance/photo-gallery-home-loan-emi-interest-rate-tenure-prepayment-repayment-calculator-which-prepayment-option-can-save-5516672-7-years-9-months-on-8000000-loan-30-calculations-saving-tips-strategy-337578

Reduce Home Loan EMI vs Reduce Tenure: Which prepayment option can help save Rs 55 lakh, & 7 years and 9 months on Rs 80 lakh, 30-year loan

https://www.zeebiz.com/startups/news-success-story-of-vineeta-singh-co-founder-of-sugar-cosmetics-how-she-left-rs-1-crore-package-now-running-rs-4000-crore-business-shark-tank-india-337168

Vineeta Singh Success Story: Quit Rs 1 crore job, lived on Rs 10K, now owns Rs 4000 crore empire

Reported By: PTI
Written By: PTI
Updated: Fri, Nov 04, 2022
07:11 PM IST
PTI
RELATED NEWS
Promoters Samina and Rumana Hamied exit Cipla; sell 1.72% stake for Rs 2,111 crore Promoters Samina and Rumana Hamied exit Cipla; sell 1.72% stake for Rs 2,111 crore
Cipla Block Deal News: Cipla promoters offload 1.72% stake via block deals at 6% discount Cipla Block Deal News: Cipla promoters offload 1.72% stake via block deals at 6% discount
Cipla shares surge nearly 10% after positive USFDA update on Goa facility Cipla shares surge nearly 10% after positive USFDA update on Goa facility

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x